Hyoscyamine Dosage and Usage
The maximum daily dose of hyoscyamine is 1.5 mg for adults, administered as 0.125 mg orally/sublingually every 4 hours as needed, with dosing adjusted based on patient age, weight, and clinical indication. 1, 2
Standard Adult Dosing
For adults and pediatric patients ≥12 years:
- Oral drops: 1-2 mL every 4 hours as needed (maximum 12 mL/24 hours) 2
- Elixir: 1-2 teaspoonfuls every 4 hours as needed (maximum 12 teaspoonfuls/24 hours) 2
- Tablets/sublingual: 0.125 mg every 4 hours as needed (maximum 1.5 mg/24 hours) 1
Pediatric Dosing
For children 2 to <12 years:
- Weight-based dosing is essential, with maximum daily limits strictly observed 2
- Oral drops: 0.25-1 mL every 4 hours (maximum 6 mL/24 hours) 2
- Elixir dosing by weight:
- 10 kg (22 lb): 1.25 mL (1/4 teaspoon)
- 20 kg (44 lb): 2.5 mL (1/2 teaspoon)
- 40 kg (88 lb): 3.75 mL (3/4 teaspoon)
- 50 kg (110 lb): 5 mL (1 teaspoon)
- Maximum 6 teaspoonfuls/24 hours 2
For infants <2 years:
- Dosing is strictly weight-based using oral drops 2
- 3.4 kg (7.5 lb): 4 drops every 4 hours (maximum 24 drops/24 hours)
- 5 kg (11 lb): 5 drops every 4 hours (maximum 30 drops/24 hours)
- 7 kg (15 lb): 6 drops every 4 hours (maximum 36 drops/24 hours)
- 10 kg (22 lb): 8 drops every 4 hours (maximum 48 drops/24 hours) 2
Clinical Applications
Palliative Care - Excessive Secretions:
- Hyoscyamine 0.125 mg PO/ODT/SL every 4 hours as needed is a second-line option when glycopyrrolate is insufficient 1
- Alternative routes (rectal, transdermal, subcutaneous, IV) may be used when oral administration is not feasible 1
Malignant Bowel Obstruction:
- Used as an anticholinergic agent when other measures fail, alongside scopolamine and glycopyrrolate 1
- Administered via alternative routes when oral intake is compromised 1
Chronic Abdominal Pain:
- Can be used as an antispasmodic in hypermobile Ehlers-Danlos syndrome and related conditions 1
Safety Monitoring and Contraindications
Monitor for anticholinergic side effects:
- Dry mouth, urinary retention, constipation, and blurred vision are common 1
- In elderly or post-stroke patients, hyoscyamine may cause more CNS effects compared to glycopyrrolate, which does not cross the blood-brain barrier 1
Use with extreme caution or avoid in:
- Cardiac patients with tachycardia, angina, or cardiac failure 3
- Prostatic hypertrophy with urinary retention 3
- Glaucoma patients should be counseled to seek emergency care if experiencing eye pain, redness, decreased vision, nausea, vomiting, or headache after administration 3
Clinical Considerations
Gastroesophageal reflux disease:
- Hyoscyamine and related anticholinergics increase esophageal acid reflux episodes and are not recommended for GERD treatment 4
Endoscopic procedures:
- Evidence does not support routine use during colonoscopy or gastroscopy 3
- May be considered during ERCP, though glucagon remains standard 3, 5
Cost and administration: